About the Authors
- Franklin R. Toapanta
-
* E-mail: ftoapanta@medicine.umaryland.edu (FRT); Msztein@medicine.umaryland.edu (MBS)
Affiliations Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- Paula J. Bernal
-
Affiliations Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- Stephanie Fresnay
-
Affiliations Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- Laurence S. Magder
-
Affiliation Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- Thomas C. Darton
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- Claire Jones
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- Claire S. Waddington
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- Christoph J. Blohmke
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- Brian Angus
-
Affiliation Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
- Myron M. Levine
-
Affiliations Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- Andrew J. Pollard
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- Marcelo B. Sztein
-
* E-mail: ftoapanta@medicine.umaryland.edu (FRT); Msztein@medicine.umaryland.edu (MBS)
Affiliations Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: FRT PJB MBS. Performed the experiments: FRT PJB SF. Analyzed the data: LSM FRT PJB LSM MBS. Contributed reagents/materials/analysis tools: LSM. Wrote the paper: FRT PJB LSM TCD CSW CJB BA AJP MML MBS. Set up the challenge model and generated the clinical data: TCD CSW MML AJP. Collected and processed the PBMC specimens: TCD CSW CJ CJB BA. Performed statistical analysis using the Mixed Effects Model: LSM.